- Home
- JNVR vs ADXN Comparison
JNVR vs ADXN Comparison
Compare JNVR & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JNVR
- ADXN
- Stock Information
- Founded
- JNVR 2018
- ADXN 2002
- Country
- JNVR United States
- ADXN Switzerland
- Employees
- JNVR N/A
- ADXN N/A
- Industry
- JNVR Finance: Consumer Services
- ADXN Biotechnology: Pharmaceutical Preparations
- Sector
- JNVR Finance
- ADXN Health Care
- Exchange
- JNVR Nasdaq
- ADXN Nasdaq
- Market Cap
- JNVR 93.3M
- ADXN 7.5M
- IPO Year
- JNVR 2023
- ADXN N/A
- Fundamental
- Price
- JNVR $74.49
- ADXN $7.79
- Analyst Decision
- JNVR
- ADXN Strong Buy
- Analyst Count
- JNVR 0
- ADXN 1
- Target Price
- JNVR N/A
- ADXN $30.00
- AVG Volume (30 Days)
- JNVR 1.9M
- ADXN 8.1K
- Earning Date
- JNVR 05-13-2025
- ADXN 06-05-2025
- Dividend Yield
- JNVR N/A
- ADXN N/A
- EPS Growth
- JNVR N/A
- ADXN N/A
- EPS
- JNVR N/A
- ADXN 0.06
- Revenue
- JNVR $2,099,660.00
- ADXN $701,260.00
- Revenue This Year
- JNVR N/A
- ADXN N/A
- Revenue Next Year
- JNVR N/A
- ADXN N/A
- P/E Ratio
- JNVR N/A
- ADXN $1.07
- Revenue Growth
- JNVR 4.82
- ADXN N/A
- 52 Week Low
- JNVR $3.37
- ADXN $6.51
- 52 Week High
- JNVR $79.50
- ADXN $13.27
- Technical
- Relative Strength Index (RSI)
- JNVR 69.20
- ADXN 53.69
- Support Level
- JNVR $48.20
- ADXN $7.69
- Resistance Level
- JNVR $77.83
- ADXN $8.19
- Average True Range (ATR)
- JNVR 17.49
- ADXN 0.38
- MACD
- JNVR 1.44
- ADXN 0.09
- Stochastic Oscillator
- JNVR 90.42
- ADXN 57.79
About JNVR Janover Inc.
Janover Inc is a B2B fintech marketplace providing a platform for commercial property borrowers and lenders. It provides a technology platform that connects commercial mortgage borrowers looking for debt to refinance, build, or buy commercial property including apartment buildings to commercial property lenders including banks, credit unions, REITs, debt funds, and more looking to deploy capital into commercial mortgages. The firm caters to two consumer segments: lenders and borrowers. It derives the majority of its revenue from platform fees and subscription revenue.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.